Trinity Biotech (FRA:TRB0) Cash per Share: € (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TRB0 Trinity Biotech PLC FRA:TRB0
24 GF Score
Price €63.60
GF Value €195.40
! 7 Warning Signs
View Full Analysis

What is Trinity Biotech Cash per Share?

Trinity Biotech FRA:TRB0 24 Cash per Share is € as of Mar. 2026. GuruFocus rates FRA:TRB0 with a GF Score™ of 24/100 and a GF Value™ of €195.40. The stock has 7 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Trinity Biotech's Cash per Share for the quarter that ended in Mar. 2026 was €.

Trinity Biotech  (FRA:TRB0) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Trinity Biotech Cash per Share Related Terms

Trinity Biotech Cash per Share Historical Data

* Premium members only.

The historical data trend for Trinity Biotech's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trinity Biotech Cash per Share Chart

Trinity Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 163.51 24.26 13.08 8.05 6.79

Trinity Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.26 2.12 1.84 6.79 -
FRA:TRB0
24GF Score
Trinity Biotech PLC FRA:TRB0
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trinity Biotech Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Trinity Biotech's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=4.3748137426029/0.64
=6.79

Trinity Biotech's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=/0.64
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of € mean?
Trinity Biotech (FRA:TRB0) has a Cash per Share of € as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Trinity Biotech and its competitors.
Is Trinity Biotech's Cash per Share too high?
Trinity Biotech's current Cash per Share is €. Overall, Trinity Biotech has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Trinity Biotech's Cash per Share compare to ICCM and AIDX?
Trinity Biotech's Cash per Share of € can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Trinity Biotech and its competitors. Trinity Biotech's current Cash per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trinity Biotech stock overvalued right now?
Trinity Biotech (FRA:TRB0) has a current Cash per Share of €. The stock's GF Value™ is €195.40, compared to a current price of €63.60 — trading 67.5% below its estimated fair value. The current Cash per Share is €. Trinity Biotech's overall GF Score™ is 24/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Trinity Biotech (FRA:TRB0), the current Cash per Share is € as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trinity Biotech (FRA:TRB0) Overvalued in 2026?

Based on GuruFocus' analysis, Trinity Biotech stock appears to be undervalued. The current stock price of €63.60 is trading 67.5% below its estimated GF Value™ of €195.40.

Key valuation signals for FRA:TRB0:

  • Cash per Share: €
  • GF Value™: €195.40 vs. price of €63.60 (67.5% below fair value)
  • GF Score™: 24/100 with 7 warning signs

No single metric tells the full story. See the FRA:TRB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trinity Biotech Business Description

Other Exchanges TRIB:USA
Address IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
24GF Score

Get the complete analysis for FRA:TRB0

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.60
Price
€195.40
GF Value